Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma

British Journal of Haematology

Volumn 156, Issue 5, 2012, Pages 557-557

  Marzolini, Maria ^a   Wong, Wai L ^a   Ardeshna, Kirit ^a,b   Padhani, Anwar ^a   D'Sa, Shirley ^a,b  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; MALE; NIGHT SWEAT; NOTE; PRIORITY JOURNAL; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DIFFUSION MAGNETIC RESONANCE IMAGING; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDNISONE; PROCARBAZINE; RADIOPHARMACEUTICALS; TREATMENT OUTCOME; VINCRISTINE;

EID: 84857034565     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08959.x     Document Type: Note

References (0)